Popular Articles
Burdock Root

Hospitals Receive AHA Award For Improving Community Health Through Effective Collaborative Projects
The American Hospital Association (AHA) announced the winners of the AHA NOVA Award. These five collaborative hospital-led programs work to improve community health by improving health habits and other social and educational factors leading to better health status and improving access to care. Each program will be honored at a July 25 ceremony held during the association"s annual Health Forum Leadership Summit in San Francisco.
generic viagra online
Cardium Provides Update On Phase 2b Excellarate Clinical Study And Plans For Additional Tissue Repair Applications
Cardium Therapeutics (NYSE Amex: CXM) and its subsidiary Tissue Repair Company (TRC) provided an update on the completion of their MATRIX Phase 2b clinical study and announced plans to provide detailed safety and efficacy data for their Excellarate(TM) product candidate around the end of September. The MATRIX trial, a prospective, randomized, double-blind, placebo-controlled study, has enrolled 124 diabetic patients with non-healing, lower extremity neuropathic ulcers.
News of the day
New Glucose-regulating Protein Linked With Diabetes Discovered By UCSF
Researchers at the University of California, San Francisco, and collaborators at Harvard Medical School have linked a specialized protein in human muscles to the process that clears glucose out of the bloodstream, shedding light on what goes wrong in type 2 diabetes on a cellular level.
Oncology

CE Mark Extended For Disc Dynamics' DASCOR(R) Disc Arthroplasty System

Disc Dynamics, Inc., a leading developer of minimally invasive treatment options for low back pain caused by degenerative disc disease (DDD), announced that the CE Mark received in the European Union for its DASCOR® Disc Arthroplasty System has been expanded to incorporate a posterior-lateral surgical approach, as well as an endoscopic approach. "DASCOR is the only motion preservation technology that can be delivered through multiple surgical approaches," said Steven Healy, president and CEO of Disc Dynamics. "Surgeons can now match the preferred surgical technique with the patient"s anatomy." The device consists of a two-part curable polyurethane and an expandable polyurethane balloon that is inserted into the disc nucleus space after the desiccated nucleus has been removed. The balloon is then injected with a flowable polymer, which creates a complete, patient-specific implant that conforms to the shape and size of the disc space. In the U.S., Disc Dynamics is currently completing its IDE feasibility clinical study. Disc Dynamics


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):